<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>3 month f/u</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Aspirin 81 81 MG</td><td ID="instruction1">1 tablet Orally Four times a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Entresto 24-26 MG</td><td ID="instruction2">1 tablet Orally Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Metoprolol Succinate ER 25 MG</td><td ID="instruction3">TAKE 1 TABLET BY MOUTH EVERY DAY Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Losartan Potassium 25 MG</td><td ID="instruction4">TAKE 1 TABLET BY MOUTH EVERY DAY Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Spironolactone 25 MG</td><td ID="instruction5">1 tablet Orally Once a day for 90 days</td><td/><td/><td>[REDACTED]</td><td>Active</td></tr><tr><td ID="medication6">Tamsulosin HCl 0.4 MG</td><td ID="instruction6">1 capsule at bed time Orally Once a day for 100 days</td><td/><td>[REDACTED]</td><td>[REDACTED]</td><td>Active</td></tr><tr><td ID="medication7">Atorvastatin Calcium 20 MG</td><td ID="instruction7">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Ozempic (0.25 or 0.5 MG/DOSE) 2 MG/1.5ML</td><td ID="instruction8">0.25 mg Subcutaneous weekly</td><td ID="medication8notes">PRESCRIBED BY CARDIO</td><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Former Smoker</td><td>[REDACTED] - [REDACTED]</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Are you a</td><td>former smoker</td><td/></tr><tr><td>When did you start smoking?</td><td>[REDACTED]</td><td/></tr><tr><td>When did you stop smoking?</td><td>[REDACTED]</td><td/></tr><tr><td>How long has it been since you last smoked?</td><td>&gt; 10 years</td><td/></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.3 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>110 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>70 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Heart Rate</th><td>82 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Height</th><td>67.13 in</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Weight</th><td>269 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital7">BMI</th><td>41.96 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital8">Oximetry</th><td>93 %</td><td>[REDACTED]</td></tr><tr><th ID="vital9">Height-cm</th><td>170.5 cm</td><td>[REDACTED]</td></tr><tr><th ID="vital10">Weight-kg</th><td>122.02 kg</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>HHC - Express</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>HFrEF (heart failure with reduced ejection fraction) I50.20 ; Primary hypertension I10 ; Benign prostatic hyperplasia without lower urinary tract symptoms N40.0 ; Morbid obesity E66.01 ; HYPERLIPIDEMIA E78.5 ; Fatigue, unspecified type R53.83 ; Hyperglycemia R73.9 ; Mixed hyperlipidemia E78.2 ; Elevated PSA R97.20 ; Hyperuricemia E79.0 and Body mass index (BMI) of 40.1 to 44.9 in adult Z68.41</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>HFrEF (heart failure with reduced ejection fraction) (ICD-10 - I50.20)</td><td/><td>states he ran out of [REDACTED], will send for pt. </td><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Primary hypertension (ICD-10 - I10)</td><td/><td><p>-DASH diet</p><p>- cont meds to keep bp in good control</p><p>- regular exercise</p><p>-low Na diet</p><p>- on meds to keep bp &lt;140/90</p><p>- compliance to diet , exercise and medication</p><p>- limit salt intake</p></td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Benign prostatic hyperplasia without lower urinary tract symptoms (ICD-10 - N40.0)</td><td/><td>psa ordered</td><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Morbid obesity (ICD-10 - E66.01)</td><td/><td>decrase calories, cont current care</td><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>HYPERLIPIDEMIA (ICD-10 - E78.5)</td><td/><td>hld. cont current care</td><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Fatigue, unspecified type (ICD-10 - R53.83)</td><td/><td>Check TSH/T3/T4 to evaluate for secondary causes of fatigue. Check CBC to screen for any metabolic disorder. </td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Hyperglycemia (ICD-10 - R73.9)</td><td/><td>Patient educated about insulin resistance in the setting of too much Carbohydrate and sugar consumption. Patient advised to improve diet and physical acivity to keep HgbA1C low. Check HgA1C value. Check annual microalbumin:cr ratio to assess for possible CKD.</td><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>Advised patient on making lifestyle modification as part of treatment.Discussed with the patient at length regarding food choices, portion control, and exercise regimen. Increase vegetable and dietary fiber intake. Avoid Alcohol use and processed foods. Exercise at least 120 min a week. Check Lipid panel to evaluate hyperlipidemia. Check CMP to screen for any metabolic disorder. </td><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Elevated PSA (ICD-10 - R97.20)</td><td/><td><p>discussed with patient about the results of elevated PSA. Risks and benefit of testing and treatment reviewed. Patient agrees to proceed with PSA test</p><p>patient to follow up with Urology for further work up and treatment plan</p></td><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Hyperuricemia (ICD-10 - E79.0)</td><td/><td/><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Body mass index (BMI) of 40.1 to 44.9 in adult (ICD-10 - Z68.41)</td><td/><td/><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Entresto 24-26 MG</td><td>1 tablet Orally Twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Metoprolol Succinate ER 25 MG</td><td>TAKE 1 TABLET BY MOUTH EVERY DAY Oral Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds3">Losartan Potassium 25 MG</td><td>TAKE 1 TABLET BY MOUTH EVERY DAY Oral Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds4">Spironolactone 25 MG</td><td>1 tablet Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/></tr><tr><td ID="potMeds5">Tamsulosin HCl 0.4 MG</td><td>1 capsule at bed time Orally Once a day for 100 days</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td ID="potMeds6">Atorvastatin Calcium 20 MG</td><td>1 tablet Oral Once a day for 90 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">HFrEF (heart failure with reduced ejection fraction)</td><td>states he ran out of entresto, will send for pt. </td></tr><tr><td ID="instructionpot2">Primary hypertension</td><td><p>-DASH diet</p><p>- cont meds to keep bp in good control</p><p>- regular exercise</p><p>-low Na diet</p><p>- on meds to keep bp &lt;140/90</p><p>- compliance to diet , exercise and medication</p><p>- limit salt intake</p></td></tr><tr><td ID="instructionpot3">Benign prostatic hyperplasia without lower urinary tract symptoms</td><td>psa ordered</td></tr><tr><td ID="instructionpot4">Morbid obesity</td><td>decrase calories, cont current care</td></tr><tr><td ID="instructionpot5">HYPERLIPIDEMIA</td><td>hld. cont current care</td></tr><tr><td ID="instructionpot6">Fatigue, unspecified type</td><td>Check TSH/T3/T4 to evaluate for secondary causes of fatigue. Check CBC to screen for any metabolic disorder. </td></tr><tr><td ID="instructionpot7">Hyperglycemia</td><td>Patient educated about insulin resistance in the setting of too much Carbohydrate and sugar consumption. Patient advised to improve diet and physical acivity to keep HgbA1C low. Check HgA1C value. Check annual microalbumin:cr ratio to assess for possible CKD.</td></tr><tr><td ID="instructionpot8">Mixed hyperlipidemia</td><td>Advised patient on making lifestyle modification as part of treatment.Discussed with the patient at length regarding food choices, portion control, and exercise regimen. Increase vegetable and dietary fiber intake. Avoid Alcohol use and processed foods. Exercise at least 120 min a week. Check Lipid panel to evaluate hyperlipidemia. Check CMP to screen for any metabolic disorder. </td></tr><tr><td ID="instructionpot9">Elevated PSA</td><td><p>discussed with patient about the results of elevated PSA. Risks and benefit of testing and treatment reviewed. Patient agrees to proceed with PSA test</p><p>patient to follow up with Urology for further work up and treatment plan</p></td></tr></tbody></table><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">MICROALBUMIN, RANDOM URINE (W/CREATININE)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">LIPID PANEL, STANDARD</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">PSA (FREE AND TOTAL)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">T3, FREE</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest5">HEMOGLOBIN A1c</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest6">CBC (INCLUDES DIFF/PLT)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest7">T4, FREE</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest8">TSH</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest9">URIC ACID</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest10">COMPREHENSIVE METABOLIC PANEL</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 6 Months, Reason: </td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 29197 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>29197</td><td align="right"><span class="bold">Provider: </span>[REDACTED], DO</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>69 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED][REDACTED][REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. 3 month f/u. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">New/Follow-up Patient</span>: <br/>      Problem 1 patient is a [REDACTED] male here [REDACTED] for a check up. No fevers, chills, slight weight loss from previous visit. <br/>         <content class="underline">Arthritis <br/>         </content>-received a corticosteroid injection to bilateral knees from orthopedics more than 1 mo ago, reports that it did not help <br/>         -occasional numbness on R thigh, no burning or tingling <br/>         <br/>         next appt with cardio for checkup: 09/2024<br/>         -will follow up on Ozempic dosing . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">All Other Systems</span>: <br/>      Review of Systems (ROS) <span class="bold">All others negative except those mentioned in HPI</span>.   <br/>   <span class="Underline">General/Constitutional</span>: <br/>      Fair Overall health. Denies Change in appetite. Denies Chills. Denies Fatigue. Denies Fever. Denies Lightheadedness. Denies Sleep disturbance.   <br/>   <span class="Underline">Allergy/Immunology</span>: <br/>      Denies Hives. Denies Unusual reaction to medication(s), food, animals or insects.   <br/>   <span class="Underline">ENT</span>: <br/>      Denies Broken nose. Denies Ear pain. Denies Masses.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Denies Hemoptysis. Denies Shortness of breath at rest. Denies Wheezing.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Denies Chest pain. Denies Cyanosis. Denies Palpitations.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Denies Abdominal pain. Denies Blood in stool. Denies Hematemesis.   <br/>   <span class="Underline">Hematology</span>: <br/>      Denies Bleeding problems. Denies Easy bruising. Denies Prolonged bleeding.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Denies Blood in urine. Denies Difficulty urinating. Denies Painful urination.   <br/>   <span class="Underline">Neurologic</span>: <br/>      Denies Fainting. Denies Paralysis. Denies Seizures.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Denies Auditory/visual hallucinations. Denies Nervous breakdown. Denies Psychiatric condition.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> Hypertension, Hyperlipidemia, Arthritis, COPD, Skin Disorder, HFrEF 20% [REDACTED], dx 3/2021, Hx of n-stemi 03/2021.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> Vein Stripping 2005. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> [REDACTED], SOB 10/2021, [REDACTED], SOB 03/2022. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Mother:  diagnosed with High cholesterol, Essential (primary) hypertension. Father:  diagnosed with Essential (primary) hypertension, High cholesterol. Siblings:  diagnosed with High cholesterol, Essential (primary) hypertension. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking <br/>         Are you a <span class="italics">former smoker</span><br/>         When did you start smoking? <span class="italics">[REDACTED]</span><br/>         When did you stop smoking? <span class="italics">[REDACTED]</span><br/>         How long has it been since you last smoked? <span class="italics">&gt; 10 years</span><br/>   <span class="Underline">Drugs/Alcohol:</span> <br/>       Drugs: no . <br/>      Alcohol Screen (Audit-C) <br/>         Did you have a drink containing alcohol in the past year? <span class="italics">No</span><br/>         Points <span class="italics">0</span><br/>         Interpretation <span class="italics">Negative</span><br/>      Caffeine <br/>         Intake: <span class="italics">1-2 cups per day</span><br/>      Do you drink alcohol?: No. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking Ozempic (0.25 or 0.5 MG/DOSE) 2 MG/1.5ML Solution Pen-injector 0.25 mg Subcutaneous weekly , Notes to Pharmacist: PRESCRIBED BY CARDIO, Taking Entresto 24-26 MG Tablet 1 tablet Orally Twice a day , Notes to Pharmacist: PRESCRIBED BY CARDIO, Taking Atorvastatin Calcium 20 MG Tablet 1 tablet Oral Once a day , Taking Aspirin 81 81 MG Tablet Delayed Release 1 tablet Orally Four times a day , Taking Tamsulosin HCl 0.4 MG Capsule 1 capsule at bed time Orally Once a day , stop date [REDACTED], Taking Metoprolol Succinate ER 25 MG Tablet Extended Release 24 Hour TAKE 1 TABLET BY MOUTH EVERY DAY Oral Once a day , Taking Spironolactone 25 MG Tablet 1 tablet Orally Once a day , Not-Taking Losartan Potassium 25 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY Oral Once a day , Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Wt: <span class="bold">269</span> lbs, Wt-kg: 122.02 kg, Ht-cm: 170.5 cm, Ht: 67.13 in, [REDACTED]: <span class="bold">110/70</span> mm Hg, HR: <span class="bold">82</span> /min, Oxygen sat %: <span class="bold">93</span> %, Temp: <span class="bold">97.3</span> F, BMI: <span class="bold">41.96</span> Index.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:COMPREHENSIVE METABOLIC PANEL</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">03:29 PM</td><td align="left">12:17 PM</td><td align="left">02:50 PM</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">GLOBULIN</td><td align="left">2.8<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.8<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.8<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td></tr><tr><td align="left">CARBON DIOXIDE</td><td align="left">29<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">24<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">29<br/>(Ref Range: 20-32 mmol/L)</td></tr><tr><td align="left">ALBUMIN/GLOBULIN RATIO</td><td align="left">1.5<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.5<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.5<br/>(Ref Range: 1.0-2.5 (calc))</td></tr><tr><td align="left">BILIRUBIN, TOTAL</td><td align="left">0.9<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">0.6<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">0.6<br/>(Ref Range: 0.2-1.2 mg/dL)</td></tr><tr><td align="left">ALKALINE PHOSPHATASE</td><td align="left">52<br/>(Ref Range: 35-144 U/L)</td><td align="left">55<br/>(Ref Range: 35-144 U/L)</td><td align="left">63<br/>(Ref Range: 35-144 U/L)</td></tr><tr><td align="left">CHLORIDE</td><td align="left">102<br/>(Ref Range: 98-110 mmol/L)</td><td align="left">106<br/>(Ref Range: 98-110 mmol/L)</td><td align="left">102<br/>(Ref Range: 98-110 mmol/L)</td></tr><tr><td align="left">AST</td><td align="left">14<br/>(Ref Range: 10-35 U/L)</td><td align="left">13<br/>(Ref Range: 10-35 U/L)</td><td align="left">18<br/>(Ref Range: 10-35 U/L)</td></tr><tr><td align="left">ALT</td><td align="left">19<br/>(Ref Range: 9-46 U/L)</td><td align="left">15<br/>(Ref Range: 9-46 U/L)</td><td align="left">23<br/>(Ref Range: 9-46 U/L)</td></tr><tr><td align="left">POTASSIUM</td><td align="left">4.4<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.0<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.5<br/>(Ref Range: 3.5-5.3 mmol/L)</td></tr><tr><td align="left">BUN/CREATININE RATIO</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td></tr><tr><td align="left">GLUCOSE</td><td align="left">99<br/>(Ref Range: 65-99 mg/dL)</td><td class="bold" align="left">105    H<br/>(Ref Range: 65-99 mg/dL)</td><td class="bold" align="left">103    H<br/>(Ref Range: 65-99 mg/dL)</td></tr><tr><td align="left">ALBUMIN</td><td align="left">4.2<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">4.2<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">4.3<br/>(Ref Range: 3.6-5.1 g/dL)</td></tr><tr><td align="left">SODIUM</td><td align="left">140<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">140<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">139<br/>(Ref Range: 135-146 mmol/L)</td></tr><tr><td align="left">CREATININE</td><td align="left">0.78<br/>(Ref Range: 0.70-1.35 mg/dL)</td><td align="left">0.84<br/>(Ref Range: 0.70-1.35 mg/dL)</td><td align="left">0.92<br/>(Ref Range: 0.70-1.35 mg/dL)</td></tr><tr><td align="left">PROTEIN, TOTAL</td><td align="left">7.0<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">7.0<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">7.1<br/>(Ref Range: 6.1-8.1 g/dL)</td></tr><tr><td align="left">CALCIUM</td><td align="left">9.5<br/>(Ref Range: 8.6-10.3 mg/dL)</td><td align="left">9.4<br/>(Ref Range: 8.6-10.3 mg/dL)</td><td align="left">9.3<br/>(Ref Range: 8.6-10.3 mg/dL)</td></tr><tr><td align="left">UREA NITROGEN (BUN)</td><td align="left">17<br/>(Ref Range: 7-25 mg/dL)</td><td align="left">21<br/>(Ref Range: 7-25 mg/dL)</td><td align="left">19<br/>(Ref Range: 7-25 mg/dL)</td></tr><tr><td align="left">EGFR</td><td align="left">97<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">95<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">91<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:TSH</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">03:29 PM</td><td align="left">12:17 PM</td><td align="left">02:50 PM</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">TSH</td><td align="left">1.17<br/>(Ref Range: 0.40-4.50 mIU/L)</td><td align="left">1.95<br/>(Ref Range: 0.40-4.50 mIU/L)</td><td align="left">1.57<br/>(Ref Range: 0.40-4.50 mIU/L)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:T4, FREE</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">03:29 PM</td><td align="left">12:17 PM</td><td align="left">02:50 PM</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">T4, FREE</td><td align="left">1.2<br/>(Ref Range: 0.8-1.8 ng/dL)</td><td align="left">1.1<br/>(Ref Range: 0.8-1.8 ng/dL)</td><td align="left">1.0<br/>(Ref Range: 0.8-1.8 ng/dL)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CBC (INCLUDES DIFF/PLT)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">03:29 PM</td><td align="left">12:17 PM</td><td align="left">02:50 PM</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">WHITE BLOOD CELL COUNT</td><td align="left">6.5<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td><td align="left">4.8<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td><td align="left">5.5<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td></tr><tr><td align="left">RED BLOOD CELL COUNT</td><td align="left">5.29<br/>(Ref Range: 4.20-5.80 Million/uL)</td><td align="left">5.38<br/>(Ref Range: 4.20-5.80 Million/uL)</td><td align="left">5.26<br/>(Ref Range: 4.20-5.80 Million/uL)</td></tr><tr><td align="left">HEMOGLOBIN</td><td align="left">15.3<br/>(Ref Range: 13.2-17.1 g/dL)</td><td align="left">15.4<br/>(Ref Range: 13.2-17.1 g/dL)</td><td align="left">15.4<br/>(Ref Range: 13.2-17.1 g/dL)</td></tr><tr><td align="left">MPV</td><td align="left">8.8<br/>(Ref Range: 7.5-12.5 fL)</td><td align="left">10.0<br/>(Ref Range: 7.5-12.5 fL)</td><td align="left">9.5<br/>(Ref Range: 7.5-12.5 fL)</td></tr><tr><td align="left">HEMATOCRIT</td><td align="left">47.4<br/>(Ref Range: 38.5-50.0 %)</td><td align="left">48.2<br/>(Ref Range: 38.5-50.0 %)</td><td align="left">46.1<br/>(Ref Range: 38.5-50.0 %)</td></tr><tr><td align="left">MCV</td><td align="left">89.6<br/>(Ref Range: 80.0-100.0 fL)</td><td align="left">89.6<br/>(Ref Range: 80.0-100.0 fL)</td><td align="left">87.6<br/>(Ref Range: 80.0-100.0 fL)</td></tr><tr><td align="left">MCH</td><td align="left">28.9<br/>(Ref Range: 27.0-33.0 pg)</td><td align="left">28.6<br/>(Ref Range: 27.0-33.0 pg)</td><td align="left">29.3<br/>(Ref Range: 27.0-33.0 pg)</td></tr><tr><td align="left">RDW</td><td align="left">14.3<br/>(Ref Range: 11.0-15.0 %)</td><td align="left">14.0<br/>(Ref Range: 11.0-15.0 %)</td><td align="left">13.8<br/>(Ref Range: 11.0-15.0 %)</td></tr><tr><td align="left">PLATELET COUNT</td><td align="left">166<br/>(Ref Range: 140-400 Thousand/uL)</td><td align="left">163<br/>(Ref Range: 140-400 Thousand/uL)</td><td align="left">186<br/>(Ref Range: 140-400 Thousand/uL)</td></tr><tr><td align="left">NEUTROPHILS</td><td align="left">63.4<br/>(Ref Range: %)</td><td align="left">62.9<br/>(Ref Range: %)</td><td align="left">60.2<br/>(Ref Range: %)</td></tr><tr><td align="left">MCHC</td><td align="left">32.3<br/>(Ref Range: 32.0-36.0 g/dL)</td><td align="left">32.0<br/>(Ref Range: 32.0-36.0 g/dL)</td><td align="left">33.4<br/>(Ref Range: 32.0-36.0 g/dL)</td></tr><tr><td align="left">ABSOLUTE BASOPHILS</td><td align="left">20<br/>(Ref Range: 0-200 cells/uL)</td><td align="left">19<br/>(Ref Range: 0-200 cells/uL)</td><td align="left">39<br/>(Ref Range: 0-200 cells/uL)</td></tr><tr><td align="left">ABSOLUTE NEUTROPHILS</td><td align="left">4121<br/>(Ref Range: 1500-7800 cells/uL)</td><td align="left">3019<br/>(Ref Range: 1500-7800 cells/uL)</td><td align="left">3311<br/>(Ref Range: 1500-7800 cells/uL)</td></tr><tr><td align="left">LYMPHOCYTES</td><td align="left">26.2<br/>(Ref Range: %)</td><td align="left">25.5<br/>(Ref Range: %)</td><td align="left">25.9<br/>(Ref Range: %)</td></tr><tr><td align="left">ABSOLUTE LYMPHOCYTES</td><td align="left">1703<br/>(Ref Range: 850-3900 cells/uL)</td><td align="left">1224<br/>(Ref Range: 850-3900 cells/uL)</td><td align="left">1425<br/>(Ref Range: 850-3900 cells/uL)</td></tr><tr><td align="left">MONOCYTES</td><td align="left">7.9<br/>(Ref Range: %)</td><td align="left">7.5<br/>(Ref Range: %)</td><td align="left">7.5<br/>(Ref Range: %)</td></tr><tr><td align="left">ABSOLUTE MONOCYTES</td><td align="left">514<br/>(Ref Range: 200-950 cells/uL)</td><td align="left">360<br/>(Ref Range: 200-950 cells/uL)</td><td align="left">413<br/>(Ref Range: 200-950 cells/uL)</td></tr><tr><td align="left">BASOPHILS</td><td align="left">0.3<br/>(Ref Range: %)</td><td align="left">0.4<br/>(Ref Range: %)</td><td align="left">0.7<br/>(Ref Range: %)</td></tr><tr><td align="left">ABSOLUTE EOSINOPHILS</td><td align="left">143<br/>(Ref Range: 15-500 cells/uL)</td><td align="left">178<br/>(Ref Range: 15-500 cells/uL)</td><td align="left">314<br/>(Ref Range: 15-500 cells/uL)</td></tr><tr><td align="left">EOSINOPHILS</td><td align="left">2.2<br/>(Ref Range: %)</td><td align="left">3.7<br/>(Ref Range: %)</td><td align="left">5.7<br/>(Ref Range: %)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:HEMOGLOBIN A1c</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">03:29 PM</td><td align="left">12:17 PM</td><td align="left">02:50 PM</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">HEMOGLOBIN A1c</td><td class="bold" align="left">5.8    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td><td class="bold" align="left">6.1    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td><td class="bold" align="left">6.2    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:T3, FREE</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">03:29 PM</td><td align="left">12:17 PM</td><td align="left">02:50 PM</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">T3, FREE</td><td align="left">3.2<br/>(Ref Range: 2.3-4.2 pg/mL)</td><td align="left">3.6<br/>(Ref Range: 2.3-4.2 pg/mL)</td><td align="left">3.6<br/>(Ref Range: 2.3-4.2 pg/mL)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:PSA, TOTAL WITH REFLEX TO PSA, FREE (REFL) (Order Date - [REDACTED]) (Collection Date &amp; Time - [REDACTED] 03:29 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        PSA, TOTAL</td><td align="left">1.0</td><td align="left"/><td align="left">&lt; OR = 4.0 - ng/mL</td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:LIPID PANEL, STANDARD</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left">03:29 PM</td><td align="left">12:17 PM</td><td align="left">02:50 PM</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">TRIGLYCERIDES</td><td align="left">125<br/>(Ref Range: &lt;150 mg/dL)</td><td align="left">97<br/>(Ref Range: &lt;150 mg/dL)</td><td align="left">148<br/>(Ref Range: &lt;150 mg/dL)</td></tr><tr><td align="left">CHOLESTEROL, TOTAL</td><td align="left">130<br/>(Ref Range: &lt;200 mg/dL)</td><td align="left">134<br/>(Ref Range: &lt;200 mg/dL)</td><td align="left">142<br/>(Ref Range: &lt;200 mg/dL)</td></tr><tr><td align="left">HDL CHOLESTEROL</td><td align="left">51<br/>(Ref Range: &gt; OR = 40 mg/dL)</td><td align="left">53<br/>(Ref Range: &gt; OR = 40 mg/dL)</td><td align="left">48<br/>(Ref Range: &gt; OR = 40 mg/dL)</td></tr><tr><td align="left">LDL-CHOLESTEROL</td><td align="left">58<br/>(Ref Range: mg/dL (calc))</td><td align="left">63<br/>(Ref Range: mg/dL (calc))</td><td align="left">71<br/>(Ref Range: mg/dL (calc))</td></tr><tr><td align="left">CHOL/HDLC RATIO</td><td align="left">2.5<br/>(Ref Range: &lt;5.0 (calc))</td><td align="left">2.5<br/>(Ref Range: &lt;5.0 (calc))</td><td align="left">3.0<br/>(Ref Range: &lt;5.0 (calc))</td></tr><tr><td align="left">NON HDL CHOLESTEROL</td><td align="left">79<br/>(Ref Range: &lt;130 mg/dL (calc))</td><td align="left">81<br/>(Ref Range: &lt;130 mg/dL (calc))</td><td align="left">94<br/>(Ref Range: &lt;130 mg/dL (calc))</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      GENERAL APPEARANCE: alert, well hydrated, in no acute distress. <br/>      HEENT PERRL bilaterally, EOMI bilaterally. <br/>      HEART: regular rate and rhythm . <br/>      LUNGS: clear to auscultation bilaterally , no wheezes, rales, rhonchi. <br/>      ABDOMEN: soft, nontender, nondistended. <br/>      SKIN: normal, no visible suspicious lesions. <br/>      NECK/THYROID: no thyromegaly, no masses. <br/>      MUSCULOSKELETAL: 5/5 strength test LE, - straight leg test bilaterally, +2/4 patellar reflex. <br/>      EXTREMITIES: no clubbing, cyanosis, or edema. <br/>      HEAD: normocephalic, atraumatic. <br/>      ORAL CAVITY: mucosa moist.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Elevated PSA - R97.20 (Primary)   2. HFrEF (heart failure with reduced ejection fraction) - I50.20   3. Primary hypertension - I10   4. Benign prostatic hyperplasia without lower urinary tract symptoms - N40.0   5. Morbid obesity - E66.01   <content><span class="bold">Specify : </span>Causing D84.81</content>   6. HYPERLIPIDEMIA - E78.5   7. Fatigue, unspecified type - R53.83   8. Hyperglycemia - R73.9   9. Mixed hyperlipidemia - E78.2   10. Hyperuricemia - E79.0   11. Body mass index (BMI) of 40.1 to 44.9 in adult - Z68.41   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Elevated PSA</span> <br/>     <span class="Underline">LAB: PSA (FREE AND TOTAL)</span><br/>Notes: discussed with patient about the results of elevated PSA. Risks and benefit of testing and treatment reviewed. Patient agrees to proceed with PSA test<br/>patient to follow up with Urology for further work up and treatment plan  </td></tr><tr><td/></tr><tr><td><span class="bold">2. HFrEF (heart failure with reduced ejection fraction)</span> <br/>Refill Spironolactone Tablet, 25 MG, 1 tablet, Orally, Once a day, 90 days, 90 Tablet, Refills 2; Refill Entresto Tablet, 24-26 MG, 1 tablet, Orally, Twice a day, 90 days, 180, Refills 3.  <br/>Notes: states he ran out of entresto, will send for pt.   </td></tr><tr><td/></tr><tr><td><span class="bold">3. Primary hypertension</span> <br/>Refill Metoprolol Succinate ER Tablet Extended Release 24 Hour, 25 MG, TAKE 1 TABLET BY MOUTH EVERY DAY, Oral, Once a day, 90 days, 90 Tablet, Refills 1; Refill Losartan Potassium Tablet, 25 MG, TAKE 1 TABLET BY MOUTH EVERY DAY, Oral, Once a day, 90 days, 90 Tablet, Refills 1.  <br/>Notes: -DASH diet<br/>- cont meds to keep bp in good control<br/>- regular exercise<br/>-low Na diet<br/>- on meds to keep bp &lt;140/90<br/>- compliance to diet , exercise and medication<br/>- limit salt intake  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Benign prostatic hyperplasia without lower urinary tract symptoms</span> <br/>Refill Tamsulosin HCl Capsule, 0.4 MG, 1 capsule at bed time, Orally, Once a day, 100 days, 100 Capsule, Refills 3.  <br/>Notes: psa ordered  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Morbid obesity</span> <br/>Notes: decrase calories, cont current care  </td></tr><tr><td/></tr><tr><td><span class="bold">6. HYPERLIPIDEMIA</span> <br/>Refill Atorvastatin Calcium Tablet, 20 MG, 1 tablet, Oral, Once a day, 90 days, 90, Refills 1.  <br/>Notes: hld. cont current care  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Fatigue, unspecified type</span> <br/>     <span class="Underline">LAB: T3, FREE</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT)</span><br/>     <span class="Underline">LAB: T4, FREE</span><br/>     <span class="Underline">LAB: TSH</span><br/>Notes: Check TSH/T3/T4 to evaluate for secondary causes of fatigue. <span class="bold"/>Check CBC to screen for any metabolic disorder.   </td></tr><tr><td/></tr><tr><td><span class="bold">8. Hyperglycemia</span> <br/>     <span class="Underline">LAB: MICROALBUMIN, RANDOM URINE (W/CREATININE)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c</span><br/>Notes: Patient educated about insulin resistance in the setting of too much Carbohydrate and sugar consumption. Patient advised to improve diet and physical acivity to keep HgbA1C low. Check HgA1C value. Check annual microalbumin:cr ratio to assess for possible CKD.  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Mixed hyperlipidemia</span> <br/>     <span class="Underline">LAB: LIPID PANEL, STANDARD</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL</span><br/>Notes: Advised patient on making lifestyle modification as part of treatment.Discussed with the patient at length regarding food choices, portion control, and exercise regimen. Increase vegetable and dietary fiber intake. Avoid Alcohol use and processed foods. Exercise at least 120 min a week. Check Lipid panel to evaluate hyperlipidemia. Check CMP to screen for any metabolic disorder.   </td></tr><tr><td/></tr><tr><td><span class="bold">10. Hyperuricemia</span> <br/>     <span class="Underline">LAB: URIC ACID</span></td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 1159F MED LIST DOCD IN RCRD, 3074F SYST BP LT 130 MM HG, 3078F DIAST BP &lt; 80 MM HG, G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 6 Months</td></tr></tbody></table></li></ul><br/><content><span class="bold">Care Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Problems:</span></content> </td></tr></tbody></table></li></ul><ul><li/></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , DO  on [REDACTED] 01:33 PM PDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], DO</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 10:29 AM PST</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td>New/Follow-up Patient</td><td>Problem 1</td><td colspan="2">patient is a [REDACTED] male here [REDACTED] for a check up. No fevers, chills, slight weight loss from previous visit.  Arthritis  -received a corticosteroid injection to bilateral knees from orthopedics more than 1 mo ago, reports that it did not help  -occasional numbness on R thigh, no burning or tingling   next appt with cardio for checkup: 09/2024 -will follow up on Ozempic dosing </td><td/></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="11">General Examination</td><td>GENERAL APPEARANCE:</td><td colspan="2">alert, well hydrated, in no acute distress</td><td rowspan="11"/></tr><tr><td>HEAD:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>NECK/THYROID:</td><td colspan="2">no thyromegaly, no masses</td></tr><tr><td>HEART:</td><td colspan="2">regular rate and rhythm</td></tr><tr><td>LUNGS:</td><td colspan="2">clear to auscultation bilaterally , no wheezes, rales, rhonchi</td></tr><tr><td>ABDOMEN:</td><td colspan="2">soft, nontender, nondistended</td></tr><tr><td>SKIN:</td><td colspan="2">normal, no visible suspicious lesions</td></tr><tr><td>EXTREMITIES:</td><td colspan="2">no clubbing, cyanosis, or edema</td></tr><tr><td>MUSCULOSKELETAL:</td><td colspan="2">5/5 strength test LE, - straight leg test bilaterally, +2/4 patellar reflex</td></tr><tr><td>ORAL CAVITY:</td><td colspan="2">mucosa moist</td></tr><tr><td>HEENT</td><td colspan="2">PERRL bilaterally, EOMI bilaterally</td></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>